Abstract # 1123 Bcl-2 and Bax Predict Prostate Cancer Outcome In Men Treated With Androgen Deprivation And Radiotherapy On RTOG 92-02

Presenter: Pollack, Alan

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

A. Pollack*1, J. Moughan*2, L. Khor*1, T. Al-Saleem*1, M. E. Hammond*3, V. Venkatesan*4, S. A. Rosenthal*5, G. E. Hanks*1, W. Shipley*6, H. Sandler*7. , 1Fox Chase Cancer Center, Philadelphia, PA, 2Radiation Therapy Oncology Group, Philadelphia, PA, 3LDS Hospital, Salt Lake City, UT, 4University Western Ontario, London, ON, Canada, 5Radiological Associates, Sacramento, CA, 6Massachusetts General Hospital, Boston, MA, 7Univ. Michigan, Ann Arbor, MI,

Author Disclosure:
A. Pollack, Varian Medical Systems, B. Research Grant; TAP Pharmaceuticals; AstraZeneca, D. Speakers Bureau/Honoraria; J. Moughan, None; L. Khor, None; T. Al-Saleem, None; M.E. Hammond, None; V. Venkatesan, None; S.A. Rosenthal, None; G.E. Hanks, None; W. Shipley, None; H. Sandler, None.

E-mail a friend about this abstract:
Enter email address:   

Abstracts Main Page | Logout